Management of Hypertension in Relation to Acute Coronary Syndromes and Revascularisation
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2556-2566
Author(s):
Michael Kuhl, Gregory Y.H. Lip and Chetan Varma
Hypertension in Pregnancy: Pathophysiology & Management Strategies
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2567-2579
Author(s):
V. J. Karthikeyan and Gregory Y.H. Lip
From Diabetes to Metabolic Syndrome: A View Point on An Evolving Concept
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2580-2583
Author(s):
Hoong Sern Lim and Gregory Y.H. Lip
Insights into the Platelet Releasate
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2640-2646
Author(s):
J. A. Coppinger and P. B. Maguire
Inhibition of Platelet Glycoprotein Ib and Its Antithrombotic Potential
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2684-2697
Author(s):
Karen Vanhoorelbeke, Hans Ulrichts, Gerlinde Van de Walle, Alexandre Fontayne and Hans Deckmyn
Editorial [Hot Topic: Pathogenesis and Treatment of Diabetic Complications,Retinopathy, Nephropathy and Cardiomyopathy (Executive Editor: J.L. Wilkinson-Berka)]
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2698-2698
Author(s):
Jennifer L. Wilkinson-Berka
Neuronal and Glial Cell Abnormality as Predictors of Progression of Diabetic Retinopathy
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2699-2712
Author(s):
Erica L. Fletcher, Joanna A. Phipps, Michelle M. Ward, Theresa Puthussery and Jennifer L. Wilkinson-Berka
The Podocyte: a Potential Therapeutic Target in Diabetic Nephropathy?
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2713-2720
Author(s):
Sally M. Marshall
Angiotensin II and the Cardiac Complications of Diabetes Mellitus
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2721-2729
Author(s):
K. A. Connelly, A. J. Boyle and D. J. Kelly
ACE2 and Diabetic Complications
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2730-2735
Author(s):
Rachael G. Dean and Louise M. Burrell